2 Days_1777294237270_124456903.png&w=64&q=75)
Source:
الوطن
الوطن
Ready to play
Ready to play
A clinical trial involving 567 adults found that the experimental injection “rebopetide” reduced weight by an average of 17.7% over 48 weeks among those given the highest dose, 6 mg, compared with 1.4% with placebo. Among participants receiving the highest dose, 44.4% lost at least one-fifth of their body weight, alongside improvements in health markers. Nausea, vomiting and diarrhea were the most common side effects. The drug is currently being tested in a head-to-head comparison with semaglutide involving around 1,200 people.
Notice: This Is an AI-Generated Summary
Comments (0)